Pyrazoloacridine
Term · Oncology and biomedicine · MLC-T-ONC-007110
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called acridines.
A 9-methoxy acridine compound containing a reducible 5-nitro substituent. Pyrazoloacridine appears to intercalate into DNA and inhibit RNA synthesis, DNA synthesis, and the activities of topoisomerases I and II, thereby causing cytotoxicity.
| Identifier | MLC-T-ONC-007110 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | PZA |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-007110",
"term": "Pyrazoloacridine",
"field": "Oncology and biomedicine",
"definitions": [
"A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called acridines.",
"A 9-methoxy acridine compound containing a reducible 5-nitro substituent. Pyrazoloacridine appears to intercalate into DNA and inhibit RNA synthesis, DNA synthesis, and the activities of topoisomerases I and II, thereby causing cytotoxicity."
],
"abbreviation": "PZA",
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pyrazoloacridine/"
}
Record 13,903 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.